Therapeutic strategies and mechanisms of drug resistance in anaplastic lymphoma kinase (ALK)-rearranged lung cancer
Author:
Funder
JSPS
AMED
The Vehicle Racing Commemorative Foundation
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference68 articles.
1. Entrectinib, a Pan-TRK, ROS1, and ALK inhibitor with activity in multiple molecularly defined cancer indications;Ardini;Molecular Cancer Therapeutics,2016
2. Behavioral and neurochemical alterations in mice deficient in anaplastic lymphoma kinase suggest therapeutic potential for psychiatric indications;Bilsland;Neuropsychopharmacology,2008
3. ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma;Bresler;Cancer Cell,2014
4. A case of ALK-rearranged adenocarcinoma with small cell carcinoma-like transformation and resistance to crizotinib;Cha;Journal of Thoracic Oncology,2016
5. Oncogenic mutations of ALK kinase in neuroblastoma;Chen;Nature,2008
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Successful intracranial response of lorlatinib after resistance with alectinib and brigatinib in patients with ALK‐positive lung adenocarcinoma: Implications of CNS penetration rate of brigatinib;Thoracic Cancer;2024-06-24
2. Physiologically driven nanodrug delivery system for targeted lung cancer treatment;Exploration of Medicine;2024-04-25
3. Origin, Metastasis, Harm, Recognition and Capture, and Elimination of Circulating Tumor Cells;Advanced Materials Technologies;2024-01-17
4. Alectinib continuation beyond progression in ALK-positive non-small cell lung cancer with alectinib-refractory;Translational Lung Cancer Research;2024-01
5. Non-small cell lung cancer patient with a rare UGP2-ALK fusion protein responded well to alectinib: a case report;Anti-Cancer Drugs;2023-09-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3